|
시장보고서
상품코드
1722629
프로바이오틱스 시장 보고서 : 성분, 유통 채널, 용도, 형태, 지역별(2025-2033년)Probiotics Market Report by Ingredient, Distribution Channel, Application, Form, and Region 2025-2033 |
||||||
세계 프로바이오틱스 시장 규모는 2024년 676억 달러에 달했습니다. 향후 IMARC Group은 2033년까지 시장 규모가 1,206억 달러에 달할 것으로 예상하며, 2025-2033년 연평균 성장률(CAGR)은 6.3%에 달할 것으로 전망하고 있습니다. 소화기 질환의 증가, 기능성 식품 및 음용 식품의 소비 확대, 의약품 개발의 확대가 시장 성장에 영향을 미치고 있습니다.
주요 시장 촉진요인소화기 질환의 증가는 시장 성장을 촉진하고 있습니다. 또한, 건강과 웰빙에 대한 개인의 인식이 높아짐에 따라 시장 성장을 촉진하고 있습니다.
주요 시장 동향 : 고령화 인구의 증가는 장 건강과 면역 기능을 향상시키는 프로바이오틱스에 대한 수요를 견인하고 있으며, 이에 따라 시장 전망은 양호합니다. 또한, 기능성 식품 및 음료의 소비 증가가 시장 성장을 촉진하고 있습니다.
지리적 동향 : 아시아태평양은 고령화와 함께 소화기 질환의 유병률이 증가함에 따라 가장 큰 부문을 차지하고 있습니다.
경쟁 환경 : 프로바이오틱스 산업의 주요 시장 기업은 Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG), Yakult Honsha Co.Ltd. 등이 있습니다.
도전과 기회 : 시장은 프로바이오틱스 시장의 수익과 수급 불균형에 영향을 미치는 치열한 경쟁과 시장 포화라는 도전에 직면한 반면, 주요 기업들이 프로바이오틱스를 보다 효율적이고 대량으로 생산할 수 있는 생산 기술을 개발할 수 있는 기회를 맞이하고 있습니다.
기능성 식품에 대한 수요 증가
IMARC Group의 보고서에 따르면, 세계 기능성 식품 시장 규모는 2023년 2,211억 달러에 달했으며, 2032년에는 3,689억 달러에 달할 것으로 예상됩니다. 프로바이오틱스 시장의 중요한 촉진요인 중 하나는 기능성 식품에 대한 수요 증가입니다. 소비자들은 영양과 더불어 건강상의 이점을 제공할 수 있는 음료 및 식품에 대한 관심이 높아지고 있습니다. 프로바이오틱스 함유 제품을 포함한 기능성 식품은 신체 기능을 지원하고 질병을 예방하는 중요한 공급원으로 여겨지고 있습니다. 둘째, 장 건강의 중요성에 대한 개인의 건강 의식과 인식이 높아짐에 따라 이러한 수요가 증가하고 있습니다. 사람들은 장내 세균총이 전반적인 건강 상태에 미치는 역할에 대한 지식이 높아지면서 소화기관에 도움이 되는 제품을 구매하고자 하는 열망이 커지고 있습니다. 프로바이오틱스는 장내 세균총의 균형을 맞추고 장내 환경을 개선하는 천연 제품이기 때문에 건강 지향적인 소비자들 사이에서 인기를 얻고 있습니다.
의약품 개발 확대
프로바이오틱스의 작용 기전과 치료 가능성을 규명하기 위한 연구가 진행됨에 따라, 그 효능을 입증하기 위한 양질의 임상시험의 필요성이 증가하고 있습니다. 신약 개발을 위해서는 임상적으로 검증된 프로바이오틱스 균주의 특정 건강 상태를 치료하는 데 있어 안전성과 효능을 입증하는 무작위 대조 시험을 실시해야 합니다. 이러한 임상시험은 프로바이오틱스의 치료제로서의 사용을 뒷받침하는 과학적 증거를 생성하여 소비자의 신뢰를 높이고 프로바이오틱스 시장의 성장을 촉진할 수 있습니다. 또한, 주요 기업들은 프로바이오틱스 의약품 개발에 투자하는 한편, 새로운 프로바이오틱스 균주, 제형 및 치료 용도에 대한 특허 보호에 주력하고 있습니다. 또한, 정부 기관은 제제의 안전성과 안정성을 중요시하고 있습니다. 또한, 전 세계적으로 의약품 개발 및 항생제 제조에 투자하고 있습니다. 예를 들어, 미국 보건복지부는 2022년까지 4,000만 달러를 투자하여 활성 제약 성분(API) 및 항생제 바이오 제조의 역할을 확대할 계획입니다.
동물 사료 산업의 번영
IMARC Group의 보고서에 따르면, 세계 동물 사료 시장은 2032년까지 6,747억 달러에 달할 것으로 예상됩니다. 가축과 가금류뿐만 아니라 반려동물에서도 동물의 장내 환경의 중요성이 인식되고 있습니다. 인간과 마찬가지로 장내 세균총은 소화, 영양 섭취, 면역 반응, 일반적인 건강 상태에 영향을 미치는 등 동물의 건강을 좌우하는 데 필수적입니다. 따라서 동물 생산자나 반려동물 소유주들은 장 건강과 동물의 성능 향상을 위해 동물 사료에 프로바이오틱스를 사용하는 경우가 늘고 있습니다. 프로바이오틱스는 지속가능한 개발 접근 방식과 더불어 사료 효율성 향상과 영양소 이용률로 인한 위장 장애 감소와도 관련이 있습니다. 또한, 프로바이오틱스는 동물 생산 생태계의 생산성과 지속가능성을 향상시키는 데 활용될 수 있습니다.
The global probiotics market size reached USD 67.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 120.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033. Rising digestive issues, the growing consumption of functional food and beverages, and expansion of drug development is impacting the growth of the market.
Major Market Drivers: The rising number of digestive disorders is impelling the growth of the market. Additionally, the increasing awareness among individuals about health and wellness is bolstering the market growth.
Key Market Trends: The growing aging population is driving the demand for probiotics to improve gut health and immune function, thereby offering a favorable market outlook. In addition, an increase in consumption of functional food and beverages is stimulating the market growth.
Geographical Trends: Asia Pacific holds the largest segment because of the growing prevalence of digestive issues, along with the rising aging population.
Competitive Landscape: Some of the major market players in the probiotics industry include Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd., among many others.
Challenges and Opportunities: While the market faces challenges like intense competition and market saturation, which impacts probiotics market revenue and supply-demand imbalances, it also encounters opportunities in the development of production technologies that allows key players to produce probiotics more efficiently and substantially.
Growing Demand for Functional Food
According to the IMARC Group's report the global functional food market size reached US$ 221.1 Billion in 2023 and expected to reach US$ 368.9 Billion by 2032. One of the significant drivers of the probiotics market is the growing demand for functional foods. Consumers are becoming more interested in food and beverages that can provide health benefits in addition to nutrition. Functional foods, which include products with probiotics, are considered an important source to support the functions of body and prevent disease. Secondly, an increase in health consciousness and awareness among individuals about the importance of gut health is driving this demand. As people are becoming more informed about the role of gut microbiota in overall well-being, they are eager to buy products that benefit their digestive system. Probiotics are a natural product that rebalances the microbiota to improve the gut, thus gaining popularity among health-conscious consumers.
Expansion of Drug Development
Growing research to elucidate the modes of action and therapeutic potential of probiotics is leading to the growing need for conducting high-quality clinical trials to prove their efficacy. Developing a new drug entail running randomized controlled trials that demonstrate the safety and efficacy of clinically validated probiotic strains in treating specific health conditions. These clinical studies generate scientific evidence that supports the use of probiotics as therapeutic agents, thereby boosting consumer confidence and driving probiotics market growth. Moreover, key players are investing in drug development for probiotics while focusing on obtaining patent protection for novel probiotic strains, formulations, and therapeutic applications. In addition, governing agencies are emphasizing the safety and stability of formulation. They are also investing in the manufacturing of drug development and antibiotics across the globe. For example, the Department of Health and Human Services invested $ 40 million in 2022 to expand the role of biomanufacturing for active pharmaceutical ingredients (APIs) and antibiotics.
Thriving Animal Feed Industry
The IMARC Group's report shows that the global animal feed market is expected to reach US$ 674.7 Billion by 2032. Increasingly, people are becoming aware about the viability of animal gut health, not just in livestock and poultry but also in pets. As in humans, the microbiota of the gut is essential in influencing animal health by impacting digestion, nutrient uptake, immune response, and general well-being among other roles. Consequently, animal producers and pet owners are increasingly adopting the use of probiotics in animal food for gut health and overall improvement of animal performance. Probiotics are likewise associated with the reduction of gastrointestinal disorders attributable to enhanced feed efficiency and utilization of nutrients, in addition to the sustainable nature of the development approach. Also, probiotics can be utilized to enhance the productivity and sustainability of animal production ecology.
Bacteria accounts for the majority of the market share
Bacteria have been widely researched and studied for their health benefits in relation to gut health. Bacteria like Lactobacillus and Bifidobacterium species are known for their ability to promote a healthy balance of microbiota, which is essential for digestion, nutrient absorption, and immune function. In addition, bacteria are easy to incorporate into various products like dairy products, dietary supplements, and functional foods. The well-established research is supporting the health benefits of bacterial probiotics, which is boosting the growth of the segment
Supermarkets and hypermarkets hold the largest share of the industry
Supermarkets and hypermarkets offer a broad variety of probiotic products from different brands, providing people with ample choices to suit their preferences and needs. The convenience of these stores attracts a large number of people seeking probiotics supplements and food and beverage products. Additionally, they leverage promotional strategies like discounts, special offers, and product placements to expand sales and encourage repeat purchases. Their established distribution networks also allow efficient supply chain management, ensuring consistent availability of probiotics products across the globe.
Food and beverages represent the leading market segment
The incorporation of probiotics into food and beverage products offer a convenient way for consumers to take these beneficial microorganisms into their daily diet, along with the rise in hectic working schedules of people that is encouraging the adoption of ready-to-eat (RTE) meals in which probiotics are included, such as yogurt cups, snack bars, cereal, and beverages, making it easy for people to access the health benefits of probiotics without the need for additional supplementation.
Liquid exhibits a clear dominance in the market
The liquid probiotics offer a convenient and easy-to-consume formats for probiotics, making them accessible to a broad range of consumers. These probiotics are available in various forms like drinks, shots, and concentrates, allowing people to incorporate them into their daily routines. Moreover, these probiotics have faster absorption rate compared to other forms. They also allow greater flexibility in formulations, enabling key players to create products with diverse probiotic stains and functional ingredients to target specific health issues.
Asia Pacific leads the market, accounting for the largest probiotics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for probiotics.
The growing awareness among the masses about the benefits of probiotics is strengthening the growth of the market across the region. Moreover, rising disposable income of people in countries like China, Japan, and South Korea are driving the demand for probiotic supplements and functional foods to improve digestive health and overall wellness. In addition, governing agencies are undertaking initiatives to promote the use of probiotics in food and beverage products, which is further bolstering the market growth in the region. Besides this, the growing understanding of the importance of preventive health with several studies showing the benefits of these products on immunity, cognitive health, and skincare, along with rising aging population, is catalyzing the probiotics demand. The State Council report of the People's Report of China 2021 shows that the total population of Chinese people on the mainland aged 60 or above has reached 264.02 million, including 190.64 million people aged 65 or above.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major probiotics companies have also been provided. Some of the major market players in the probiotics industry include Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Key players are investing in research and development (R&D) activities to identify new probiotics strains, enhance formulations technologies, and better understand the mechanisms of action and health benefits of probiotics. They are also working with research institutes and healthcare organizations to develop the probiotics products. Moreover, companies are prioritizing quality assurance and control measures to ensure stability and safety of their probiotics products. Key manufacturers are also expanding their product lines to include a broad variety of probiotic formulations targeting different consumers. For instance, in 2021, Lifeway Foods, Inc., the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, announced its new line of dairy-free probiotic oat beverage at natural products expo east.